Shingai Machingaidze joined EDCTP in September 2015 as a Project Officer. She received undergraduate and postgraduate training in molecular and cell biology at the University of Cape Town (UCT), South Africa where she worked on probiotic strains for Kidney Stone Disease. In 2011 she obtained a Master of Public Health in Epidemiology and Biostatistics also from UCT. Shingai is currently studying towards a PhD in Public Health.
Before joining EDCTP, Shingai worked as a researcher at UCT for five years with the South African TB Vaccine Initiative (SATVI) managing an adolescent tuberculosis cohort study, as well as with the Vaccines for Africa Initiative (VACFA) coordinating research on vaccination programmes (EPI) in Africa where she also gained experience in conducting systematic reviews. She subsequently worked with the Centre for Tuberculosis at the National Institute of Communicable Diseases where she worked on establishing a TB sentinel surveillance system as well as various projects with the National Department of Health; as well as the South African Medical Research Council where she was a Project Manager for the South African Guidelines Excellence (SAGE) Project.
Shingai has published in the fields of vaccines, TB epidemiology, clinical guidelines and translation of research into policy and practice. She is a peer-reviewer for several international medical journals, and is a member of faculty of the Annual African Vaccinology Course.
(Cape Town Office)